Raphael Diaz

463 total citations
3 papers, 354 citations indexed

About

Raphael Diaz is a scholar working on Surgery, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Raphael Diaz has authored 3 papers receiving a total of 354 indexed citations (citations by other indexed papers that have themselves been cited), including 1 paper in Surgery, 1 paper in Molecular Biology and 1 paper in Cardiology and Cardiovascular Medicine. Recurrent topics in Raphael Diaz's work include Cardiac electrophysiology and arrhythmias (1 paper), Pharmaceutical Economics and Policy (1 paper) and Gastric Cancer Management and Outcomes (1 paper). Raphael Diaz is often cited by papers focused on Cardiac electrophysiology and arrhythmias (1 paper), Pharmaceutical Economics and Policy (1 paper) and Gastric Cancer Management and Outcomes (1 paper). Raphael Diaz collaborates with scholars based in Argentina, United States and Australia. Raphael Diaz's co-authors include Christopher B. Granger, Jack Ansell, Bernard J. Gersh, John D. Horowitz, Elaine M. Hylek, Renato D. Lópes, Sana M. Al‐Khatib, John J.V. McMurray, Lars Wallentin and J. Donald Easton and has published in prestigious journals such as European Heart Journal and American Heart Journal.

In The Last Decade

Raphael Diaz

3 papers receiving 341 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Raphael Diaz Argentina	2	340	166	43	19	13	3	354
Melanie Hemmrich Germany	7	380 1.1×	143 0.9×	51 1.2×	8 0.4×	32 2.5×	9	419
Isabelle Ling Meng Germany	8	482 1.4×	192 1.2×	26 0.6×	13 0.7×	37 2.8×	9	507
Anja Katholing Australia	4	277 0.8×	83 0.5×	49 1.1×	30 1.6×	25 1.9×	7	295
Alexander G.G. Turpie Canada	8	298 0.9×	137 0.8×	49 1.1×	30 1.6×	22 1.7×	13	343
E Fantecchi Italy	8	381 1.1×	55 0.3×	36 0.8×	33 1.7×	49 3.8×	9	388
Christina Ji‐Young Lee Denmark	9	193 0.6×	45 0.3×	20 0.5×	7 0.4×	17 1.3×	25	252
Branislav Biss Austria	4	304 0.9×	118 0.7×	16 0.4×	9 0.5×	18 1.4×	6	324
Elżbieta Młodawska Poland	7	245 0.7×	50 0.3×	34 0.8×	5 0.3×	44 3.4×	19	286
H. Yang United States	3	290 0.9×	161 1.0×	51 1.2×	23 1.2×	6 0.5×	3	308
Vakaliuk Ip Ukraine	3	378 1.1×	124 0.7×	21 0.5×	12 0.6×	21 1.6×	12	392

Countries citing papers authored by Raphael Diaz

Since Specialization

Citations

This map shows the geographic impact of Raphael Diaz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raphael Diaz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raphael Diaz more than expected).

Fields of papers citing papers by Raphael Diaz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raphael Diaz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raphael Diaz. The network helps show where Raphael Diaz may publish in the future.

Co-authorship network of co-authors of Raphael Diaz

This figure shows the co-authorship network connecting the top 25 collaborators of Raphael Diaz. A scholar is included among the top collaborators of Raphael Diaz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raphael Diaz. Raphael Diaz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

3 of 3 papers shown

1.

Goodman, Shaun G., Philippe Gabríel Steg, Michael Szarek, et al.. (2022). Longer-term safety of alirocumab with 24,610 patient-years of placebo-controlled observation: further insights from the ODYSSEY OUTCOMES trial. European Heart Journal. 43(Supplement_2). 2 indexed citations

2.

Ferrannini, Giulia, Hertzel C. Gerstein, Helen M. Colhoun, et al.. (2020). Dulaglutide is cardioprotective with or without background metformin in patients with diabetes and established or high risk for coronary vascular disease. A subgroup analysis of the REWIND Trial. European Heart Journal. 41(Supplement_2). 1 indexed citations

3.

Lópes, Renato D., John H. Alexander, Sana M. Al‐Khatib, et al.. (2010). Apixaban for Reduction In Stroke and Other ThromboemboLic Events in Atrial Fibrillation (ARISTOTLE) trial: Design and rationale. American Heart Journal. 159(3). 331–339. 351 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact